Sarah Clifford
0009-0006-6292-9685
Foundation Medicine
1 paper found
Refreshing results…
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers
Missing publications? Search for publications with a matching author name.